APP Biosimilars Training Series Module 4 - Insurer-Mandated Switching and How to Effectively Communicate with Patients

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

APP Biosimilars Training Series Module 4 - Insurer-Mandated Switching and How to Effectively Communicate with Patients

By Crohn's & Colitis Foundation FEATURING Ross Maltz

258 views

September 25, 2023

This Crohn’s & Colitis Foundation training series is designed to give advanced practice providers a ...
read more ↘ better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosimilar, answer questions on efficacy compared to their originator drugs, and discuss an insurance mandated mandatory switch.

Additional Crohn's & Colitis Foundation educational resources:
https://crohnscolitisprofessional.org/clinical-topics/medical-therapy/

Upcoming Crohn's & Colitis Foundation events:
https://crohnscolitisprofessional.org/meetings/new/
↖ read less

Comments 0